Interceptor

Verify with FDA CVM →

217 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
217
Total Reports
14
Deaths Reported
650.0%
Death Rate

Active Ingredients

Interceptor

Administration Routes

OralUnknown

Species Affected

Dog 217

Most Affected Breeds

Retriever - Labrador 35
Crossbred Canine/dog 18
Retriever - Golden 12
Terrier - Bull - American Pit 11
Dog (unknown) 9
Shepherd Dog - German 9
Pit Bull 6
Boxer (German Boxer) 6
Chihuahua 6
Bulldog - French 5

Most Reported Reactions

Lack of efficacy (endoparasite) - heartworm 85
Vomiting 36
Seizure NOS 22
Diarrhoea 13
Not eating 12
Emesis (multiple) 9
Death 7
Death by euthanasia 7
Ataxia 7
Panting 6
Behavioural disorder NOS 6
Lethargy (see also Central nervous system depression in 'Neurological') 6

Outcome Breakdown

Ongoing
120 (54.8%)
Recovered/Normal
49 (22.4%)
Outcome Unknown
36 (16.4%)
Died
7 (3.2%)
Euthanized
7 (3.2%)

Data Summary

Metric Value
Total adverse event reports 217
Reports involving death 14
Case-fatality rate (reported events) 650.0%
Distinct species in reports 1
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Interceptor Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 217 adverse event reports referencing Interceptor, including 14 reports in which the animal died — a 650.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Interceptor. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Interceptor reports are Dog (217 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (35), Crossbred Canine/dog (18), Retriever - Golden (12) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Interceptor are Lack of efficacy (endoparasite) - heartworm (85), Vomiting (36), Seizure NOS (22), Diarrhoea (13). Of the 219 reports with a coded outcome, Ongoing is the leading category at 54.8%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Interceptor.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial